Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Pajak

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reports|April 1, 1984
Chlorozotocin: phase II evaluation in patients with myelomaC J Cornell, T F Pajak, O R McIntyre
International Journal of Radiation Oncology, Biology, Physics|July 30, 1995
In response to Bentzen et al., IJROBP 32:1531-1534; 1995R J Caplan, T F Pajak, J D Cox
Rays|May 23, 2001
Methodology and research by the Radiation Therapy Oncology Group (RTOG)J D Cox, T F Pajak, W J Curran
Cancer Treatment Reports|March 1, 1979
Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, O R McIntyre
International Journal of Radiation Oncology, Biology, Physics|February 15, 1993
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care studyR M Lanciano, T F Pajak, K Martz, et al.
Journal of the National Cancer Institute|August 7, 1991
Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancerM Diener-West, T F Pajak, M Bauer, et al.
Cancer Chemotherapy Reports|November 1, 1973
Study of methyl-CCNU(NSC-95441) in the treatment of lung cancerF Richards, T F Pajak, M R Cooper, et al.
Cancer Clinical Trials|January 1, 1981
Maintenance management of acute nonlymphocytic leukemiaJ P Lewis, T F Pajak, J W Linman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1987
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG)V A Marcial, T F Pajak, C Chang, et al.
Cancer Treatment Reports|October 1, 1977
Adriamycin versus adriamycin and bleomycin in advanced epidermoid carcinoma of the cervixB R Greenberg, C G Kardinal, T F Pajak, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reports|April 1, 1984
Chlorozotocin: phase II evaluation in patients with myelomaC J Cornell, T F Pajak, O R McIntyre
International Journal of Radiation Oncology, Biology, Physics|July 30, 1995
In response to Bentzen et al., IJROBP 32:1531-1534; 1995R J Caplan, T F Pajak, J D Cox
Rays|May 23, 2001
Methodology and research by the Radiation Therapy Oncology Group (RTOG)J D Cox, T F Pajak, W J Curran
Cancer Treatment Reports|March 1, 1979
Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, O R McIntyre
International Journal of Radiation Oncology, Biology, Physics|February 15, 1993
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care studyR M Lanciano, T F Pajak, K Martz, et al.
Journal of the National Cancer Institute|August 7, 1991
Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancerM Diener-West, T F Pajak, M Bauer, et al.
Cancer Chemotherapy Reports|November 1, 1973
Study of methyl-CCNU(NSC-95441) in the treatment of lung cancerF Richards, T F Pajak, M R Cooper, et al.
Cancer Clinical Trials|January 1, 1981
Maintenance management of acute nonlymphocytic leukemiaJ P Lewis, T F Pajak, J W Linman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1987
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG)V A Marcial, T F Pajak, C Chang, et al.
Cancer Treatment Reports|October 1, 1977
Adriamycin versus adriamycin and bleomycin in advanced epidermoid carcinoma of the cervixB R Greenberg, C G Kardinal, T F Pajak, et al.
Pageof 15